Article
Hematopoietic stem cells from induced pluripotent stem cells – considering the role of microRNA as a cell differentiation regulator
15 Feb 2018
Abstract excerpt
ABSTRACT Although hematopoietic stem cell (HSC) therapy for hematological diseases can lead to a good outcome from the clinical point of view, the limited number of ideal donors, the comorbidity of patients and the increasing number of elderly patients may limit the application of this therapy. HSCs can be generated from induced pluripotent stem cells (iPSCs), which requires the understanding of the bone marrow...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
